Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 1
2008 1
2009 2
2010 3
2011 1
2014 3
2015 1
2016 2
2017 2
2018 4
2019 3
2020 5
2021 1
2022 4
2023 4
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.
A traveler with neurobrucellosis.
Van den Enden E, Vlieghe E, Demeester R, Ieven G, Jansens H, Van den Hauwe L. Van den Enden E, et al. Among authors: demeester r. Travel Med Infect Dis. 2009 Jul;7(4):215-8. doi: 10.1016/j.tmaid.2009.05.004. Epub 2009 Jun 13. Travel Med Infect Dis. 2009. PMID: 19717103
A public health value-based healthcare paradigm for HIV.
Vermeersch S, Demeester RP, Ausselet N, Callens S, De Munter P, Florence E, Goffard JC, Henrard S, Lacor P, Messiaen P, Libois A, Seyler L, Uurlings F, Vandecasteele SJ, Van Wijngaerden E, Yombi JC, Annemans L, De Wit S. Vermeersch S, et al. Among authors: demeester rp. BMC Health Serv Res. 2022 Jan 2;22(1):13. doi: 10.1186/s12913-021-07371-7. BMC Health Serv Res. 2022. PMID: 34974833 Free PMC article.
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Florence E, Yombi JC, Henrard S, Darcis G, Van Praet J, Vandekerckhove L, Allard SD, Demeester R, Messiaen P, Ausselet N, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: demeester r. HIV Med. 2023 Aug;24(8):914-924. doi: 10.1111/hiv.13493. Epub 2023 Apr 10. HIV Med. 2023. PMID: 37038245 Free article.
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Yombi JC, Darcis G, Florence E, Allard SD, De Scheerder MA, Henrard S, Demeester R, Messiaen P, Ausselet N, Loeckx M, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: demeester r. HIV Med. 2023 Mar;24(3):267-278. doi: 10.1111/hiv.13373. Epub 2022 Aug 8. HIV Med. 2023. PMID: 35938381 Free article.
38 results